| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 4.63e-07 | 15 | 88 | 4 | GO:0008494 | |
| GeneOntologyBiologicalProcess | female meiosis II | 4.61e-09 | 6 | 88 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 4.61e-09 | 6 | 88 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 4.61e-09 | 6 | 88 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 1.35e-06 | 45 | 88 | 5 | GO:0040020 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 2.80e-06 | 52 | 88 | 5 | GO:0007143 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 4.30e-06 | 26 | 88 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 6.77e-06 | 29 | 88 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 8.91e-06 | 31 | 88 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 1.14e-05 | 118 | 88 | 6 | GO:2000243 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | ERCC1 SPAM1 KMT2D ANGPT2 DAZ4 DAZ1 CFAP57 DAZ3 DAZ2 VPS13B KNL1 | 1.48e-05 | 527 | 88 | 11 | GO:0022412 |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 1.83e-05 | 37 | 88 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 2.66e-05 | 82 | 88 | 5 | GO:0051445 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 3.54e-05 | 87 | 88 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | germ cell development | 3.91e-05 | 482 | 88 | 10 | GO:0007281 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 4.39e-05 | 91 | 88 | 5 | GO:0006446 | |
| GeneOntologyBiologicalProcess | female gamete generation | 4.75e-05 | 223 | 88 | 7 | GO:0007292 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 4.80e-05 | 47 | 88 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | regulation of translation | NMNAT2 POLDIP3 INPP5E DAZ4 PPP1R15B SHMT2 DAZ1 TNRC6C DAZ3 DAZ2 | 4.81e-05 | 494 | 88 | 10 | GO:0006417 |
| GeneOntologyBiologicalProcess | oogenesis | 5.53e-05 | 156 | 88 | 6 | GO:0048477 | |
| GeneOntologyBiologicalProcess | oocyte development | 6.58e-05 | 99 | 88 | 5 | GO:0048599 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 7.23e-05 | 101 | 88 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 7.94e-05 | 103 | 88 | 5 | GO:0009994 | |
| GeneOntologyBiologicalProcess | regulation of exosomal secretion | 8.12e-05 | 20 | 88 | 3 | GO:1903541 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.34e-04 | 115 | 88 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | exosomal secretion | 1.42e-04 | 24 | 88 | 3 | GO:1990182 | |
| GeneOntologyBiologicalProcess | extracellular exosome biogenesis | 1.61e-04 | 25 | 88 | 3 | GO:0097734 | |
| GeneOntologyBiologicalProcess | negative regulation of GTPase activity | 2.04e-04 | 27 | 88 | 3 | GO:0034260 | |
| GeneOntologyBiologicalProcess | extracellular vesicle biogenesis | 2.04e-04 | 27 | 88 | 3 | GO:0140112 | |
| GeneOntologyBiologicalProcess | translational initiation | 2.55e-04 | 132 | 88 | 5 | GO:0006413 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 2.98e-04 | 75 | 88 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | positive chemotaxis | 2.98e-04 | 75 | 88 | 4 | GO:0050918 | |
| GeneOntologyBiologicalProcess | response to BMP | 3.18e-04 | 215 | 88 | 6 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 3.18e-04 | 215 | 88 | 6 | GO:0071773 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 3.30e-04 | 77 | 88 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | vesicle organization | 3.96e-04 | 415 | 88 | 8 | GO:0016050 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 4.08e-04 | 34 | 88 | 3 | GO:0060977 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 4.73e-04 | 151 | 88 | 5 | GO:0045727 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 5.49e-04 | 88 | 88 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 5.70e-04 | 240 | 88 | 6 | GO:0140013 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 7.21e-04 | 251 | 88 | 6 | GO:2000241 | |
| GeneOntologyBiologicalProcess | positive regulation of BMP signaling pathway | 7.64e-04 | 42 | 88 | 3 | GO:0030513 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 7.92e-04 | 10 | 88 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | 8.40e-04 | 582 | 88 | 9 | GO:0044089 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 8.53e-04 | 172 | 88 | 5 | GO:0051783 | |
| GeneOntologyBiologicalProcess | gamete generation | ERCC1 KMT2D ANGPT2 DAZ4 MEIKIN DAZ1 CFAP57 DAZ3 DAZ2 HERPUD2 VPS13B KNL1 | 9.26e-04 | 982 | 88 | 12 | GO:0007276 |
| GeneOntologyBiologicalProcess | COPII-coated vesicle budding | 9.35e-04 | 45 | 88 | 3 | GO:0090114 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 1.01e-03 | 268 | 88 | 6 | GO:1903046 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.24e-03 | 187 | 88 | 5 | GO:0007156 | |
| GeneOntologyCellularComponent | ESCRT-0 complex | 5.36e-05 | 3 | 89 | 2 | GO:0033565 | |
| Domain | RRM_1 | 5.21e-06 | 208 | 86 | 8 | PF00076 | |
| Domain | RRM | 7.12e-06 | 217 | 86 | 8 | SM00360 | |
| Domain | RRM_dom | 9.89e-06 | 227 | 86 | 8 | IPR000504 | |
| Domain | RRM | 1.09e-05 | 230 | 86 | 8 | PS50102 | |
| Domain | ZF_CCHC_HIVEP | 2.10e-05 | 2 | 86 | 2 | PS51811 | |
| Domain | Nucleotide-bd_a/b_plait | 2.49e-05 | 258 | 86 | 8 | IPR012677 | |
| Domain | - | 1.33e-04 | 244 | 86 | 7 | 3.30.70.330 | |
| Domain | Sec23/24_helical_dom | 3.11e-04 | 6 | 86 | 2 | IPR006900 | |
| Domain | Sec23_24_beta_S | 3.11e-04 | 6 | 86 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 3.11e-04 | 6 | 86 | 2 | PF04810 | |
| Domain | Sec23_trunk | 3.11e-04 | 6 | 86 | 2 | PF04811 | |
| Domain | Sec23_helical | 3.11e-04 | 6 | 86 | 2 | PF04815 | |
| Domain | Sec23_BS | 3.11e-04 | 6 | 86 | 2 | PF08033 | |
| Domain | Sec23/24_trunk_dom | 3.11e-04 | 6 | 86 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 3.11e-04 | 6 | 86 | 2 | IPR006895 | |
| Domain | VHS | 7.39e-04 | 9 | 86 | 2 | PF00790 | |
| Domain | VHS | 7.39e-04 | 9 | 86 | 2 | PS50179 | |
| Domain | RFX_DNA_binding | 7.39e-04 | 9 | 86 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 7.39e-04 | 9 | 86 | 2 | IPR003150 | |
| Domain | VHS | 7.39e-04 | 9 | 86 | 2 | SM00288 | |
| Domain | VHS_dom | 7.39e-04 | 9 | 86 | 2 | IPR002014 | |
| Domain | RFX_DBD | 7.39e-04 | 9 | 86 | 2 | PS51526 | |
| Domain | RNAse_Pc | 1.12e-03 | 11 | 86 | 2 | SM00092 | |
| Domain | RNaseA | 1.58e-03 | 13 | 86 | 2 | PD000535 | |
| Domain | Gelsolin | 1.84e-03 | 14 | 86 | 2 | PF00626 | |
| Domain | Gelsolin-like_dom | 1.84e-03 | 14 | 86 | 2 | IPR007123 | |
| Domain | RNaseA | 2.12e-03 | 15 | 86 | 2 | IPR001427 | |
| Domain | RNaseA_domain | 2.12e-03 | 15 | 86 | 2 | IPR023412 | |
| Domain | RnaseA | 2.12e-03 | 15 | 86 | 2 | PF00074 | |
| Domain | - | 2.12e-03 | 15 | 86 | 2 | 3.10.130.10 | |
| Domain | UIM | 3.06e-03 | 18 | 86 | 2 | PF02809 | |
| Domain | UIM | 4.16e-03 | 21 | 86 | 2 | SM00726 | |
| Domain | Znf_FYVE_PHD | 4.75e-03 | 147 | 86 | 4 | IPR011011 | |
| Domain | PHD | 5.01e-03 | 75 | 86 | 3 | PF00628 | |
| Domain | ADF-H/Gelsolin-like_dom | 5.42e-03 | 24 | 86 | 2 | IPR029006 | |
| Domain | - | 5.42e-03 | 24 | 86 | 2 | 3.40.20.10 | |
| Domain | UIM | 5.42e-03 | 24 | 86 | 2 | PS50330 | |
| Domain | Znf_PHD-finger | 5.79e-03 | 79 | 86 | 3 | IPR019787 | |
| Domain | UIM_dom | 5.87e-03 | 25 | 86 | 2 | IPR003903 | |
| Pathway | WP_OVARIAN_INFERTILITY | 2.06e-05 | 35 | 66 | 4 | MM15948 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 1.23e-04 | 21 | 66 | 3 | MM15347 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 1.23e-04 | 21 | 66 | 3 | M27645 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 4.01e-11 | 4 | 89 | 4 | 15066457 | |
| Pubmed | 4.01e-11 | 4 | 89 | 4 | 7670487 | ||
| Pubmed | 4.01e-11 | 4 | 89 | 4 | 11694340 | ||
| Pubmed | 4.01e-11 | 4 | 89 | 4 | 9321470 | ||
| Pubmed | 4.01e-11 | 4 | 89 | 4 | 19223287 | ||
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 4.01e-11 | 4 | 89 | 4 | 11095434 | |
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 4.01e-11 | 4 | 89 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 4.01e-11 | 4 | 89 | 4 | 11688365 | |
| Pubmed | 4.01e-11 | 4 | 89 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 4.01e-11 | 4 | 89 | 4 | 11883873 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 4.01e-11 | 4 | 89 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 4.01e-11 | 4 | 89 | 4 | 16963411 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 4.01e-11 | 4 | 89 | 4 | 12801575 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 23579190 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 2.00e-10 | 5 | 89 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 2.00e-10 | 5 | 89 | 4 | 9288969 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 20008336 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 23456578 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 2.00e-10 | 5 | 89 | 4 | 8679003 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 2.00e-10 | 5 | 89 | 4 | 10903443 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 2.00e-10 | 5 | 89 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 2.00e-10 | 5 | 89 | 4 | 8845845 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 2.00e-10 | 5 | 89 | 4 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 2.00e-10 | 5 | 89 | 4 | 19783541 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 22293198 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 17761180 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 2.00e-10 | 5 | 89 | 4 | 12200456 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 11514340 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 11089564 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 2.00e-10 | 5 | 89 | 4 | 22223682 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 2.00e-10 | 5 | 89 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 2.00e-10 | 5 | 89 | 4 | 8968756 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 2.00e-10 | 5 | 89 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 2.00e-10 | 5 | 89 | 4 | 26411291 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 2.00e-10 | 5 | 89 | 4 | 23223451 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 34985827 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 11804965 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 2.00e-10 | 5 | 89 | 4 | 14648873 | |
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 8896558 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 9700189 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 21270429 | ||
| Pubmed | 2.00e-10 | 5 | 89 | 4 | 8661148 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 5.99e-10 | 6 | 89 | 4 | 15066460 | |
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 5.99e-10 | 6 | 89 | 4 | 18452650 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 5.99e-10 | 6 | 89 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 5.99e-10 | 6 | 89 | 4 | 31355046 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 5.99e-10 | 6 | 89 | 4 | 23417416 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 32170089 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 16278232 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 20157580 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 17219433 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 5.99e-10 | 6 | 89 | 4 | 26077710 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 5.99e-10 | 6 | 89 | 4 | 16001084 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 32962040 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 17526644 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 5.99e-10 | 6 | 89 | 4 | 1869307 | |
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 11390979 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 27632217 | ||
| Pubmed | 5.99e-10 | 6 | 89 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 5.99e-10 | 6 | 89 | 4 | 14611632 | |
| Pubmed | 8.17e-10 | 18 | 89 | 5 | 34075040 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 10857750 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 11410654 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 15081113 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 22699423 | ||
| Pubmed | 1.39e-09 | 7 | 89 | 4 | 11604102 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 1.39e-09 | 7 | 89 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 1.39e-09 | 7 | 89 | 4 | 26826184 | |
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 1.39e-09 | 7 | 89 | 4 | 16946704 | |
| Pubmed | 2.78e-09 | 8 | 89 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 2.78e-09 | 8 | 89 | 4 | 32339196 | |
| Pubmed | 2.78e-09 | 8 | 89 | 4 | 33749946 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 2.78e-09 | 8 | 89 | 4 | 23204224 | |
| Pubmed | 2.78e-09 | 8 | 89 | 4 | 29883445 | ||
| Pubmed | 2.78e-09 | 8 | 89 | 4 | 10823932 | ||
| Pubmed | 2.78e-09 | 8 | 89 | 4 | 22621333 | ||
| Pubmed | 2.78e-09 | 8 | 89 | 4 | 32686646 | ||
| Pubmed | 2.78e-09 | 8 | 89 | 4 | 11869379 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 5.00e-09 | 9 | 89 | 4 | 16310179 | |
| Pubmed | 5.00e-09 | 9 | 89 | 4 | 20159962 | ||
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 5.00e-09 | 9 | 89 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 5.00e-09 | 9 | 89 | 4 | 19695304 | |
| Pubmed | 5.00e-09 | 9 | 89 | 4 | 28235998 | ||
| Pubmed | 8.31e-09 | 10 | 89 | 4 | 10601091 | ||
| Pubmed | 8.31e-09 | 10 | 89 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 8.31e-09 | 10 | 89 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 8.31e-09 | 10 | 89 | 4 | 38433229 | |
| Pubmed | 8.31e-09 | 10 | 89 | 4 | 9922113 | ||
| Pubmed | 8.31e-09 | 10 | 89 | 4 | 23810942 | ||
| Pubmed | 8.31e-09 | 10 | 89 | 4 | 12837688 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 1.30e-08 | 11 | 89 | 4 | 34401671 | |
| Pubmed | ELAVL2-directed RNA regulatory network drives the formation of quiescent primordial follicles. | 1.58e-08 | 31 | 89 | 5 | 31657143 | |
| Pubmed | High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. | 1.62e-08 | 3 | 89 | 3 | 11870237 | |
| Interaction | KLF3 interactions | 5.90e-06 | 228 | 86 | 8 | int:KLF3 | |
| Interaction | FHL2 interactions | 7.18e-06 | 396 | 86 | 10 | int:FHL2 | |
| Interaction | EPHA8 interactions | 7.93e-06 | 169 | 86 | 7 | int:EPHA8 | |
| Interaction | ASF1A interactions | 1.12e-05 | 249 | 86 | 8 | int:ASF1A | |
| Interaction | METTL27 interactions | 1.64e-05 | 36 | 86 | 4 | int:METTL27 | |
| Interaction | CEBPA interactions | RPGRIP1 KMT2D HIVEP1 RESF1 POLDIP3 ARID2 TLN1 RBM14 ZFR QSER1 MED13L RFX1 SAP130 GATAD2B PCM1 PRDM2 KNL1 | 1.71e-05 | 1245 | 86 | 17 | int:CEBPA |
| Interaction | GATAD1 interactions | 2.07e-05 | 131 | 86 | 6 | int:GATAD1 | |
| Interaction | SP7 interactions | 4.68e-05 | 304 | 86 | 8 | int:SP7 | |
| Interaction | NFIX interactions | 5.30e-05 | 227 | 86 | 7 | int:NFIX | |
| Interaction | IFITM3 interactions | SEC24D KIF23 PTPRJ POLDIP3 UFD1 HGS SEC24B RBM14 STAM PACSIN2 | 6.55e-05 | 513 | 86 | 10 | int:IFITM3 |
| Interaction | BAG2 interactions | TRIM66 KIF23 ATXN1 AMOT TLN1 HGS QSER1 STAM RFX1 VPS13B KNL1 | 6.65e-05 | 622 | 86 | 11 | int:BAG2 |
| Interaction | SEC31A interactions | 6.77e-05 | 236 | 86 | 7 | int:SEC31A | |
| Interaction | FGFR2 interactions | 7.33e-05 | 239 | 86 | 7 | int:FGFR2 | |
| Interaction | EGR2 interactions | 9.17e-05 | 171 | 86 | 6 | int:EGR2 | |
| Interaction | BICD1 interactions | 9.70e-05 | 250 | 86 | 7 | int:BICD1 | |
| Interaction | EN1 interactions | 1.08e-04 | 110 | 86 | 5 | int:EN1 | |
| Interaction | CEP55 interactions | 1.12e-04 | 256 | 86 | 7 | int:CEP55 | |
| Interaction | IFITM1 interactions | 1.38e-04 | 355 | 86 | 8 | int:IFITM1 | |
| Interaction | MED28 interactions | 1.39e-04 | 116 | 86 | 5 | int:MED28 | |
| Interaction | TBXT interactions | 1.39e-04 | 116 | 86 | 5 | int:TBXT | |
| Interaction | HNF1B interactions | 1.63e-04 | 190 | 86 | 6 | int:HNF1B | |
| Interaction | NLRP13 interactions | 1.78e-04 | 5 | 86 | 2 | int:NLRP13 | |
| Interaction | KLF5 interactions | 1.88e-04 | 195 | 86 | 6 | int:KLF5 | |
| Interaction | TLE3 interactions | 2.04e-04 | 376 | 86 | 8 | int:TLE3 | |
| Interaction | CCDC18 interactions | 2.04e-04 | 68 | 86 | 4 | int:CCDC18 | |
| Interaction | GATA2 interactions | 2.10e-04 | 199 | 86 | 6 | int:GATA2 | |
| Interaction | FEV interactions | 2.34e-04 | 203 | 86 | 6 | int:FEV | |
| Interaction | BRCA1 interactions | RPGRIP1 ERCC1 KIF23 HIVEP1 USO1 MICAL2 TLN1 SEC24B POLR2J RBM14 ZFR TNRC6C TFG GATAD2B KNL1 | 2.39e-04 | 1249 | 86 | 15 | int:BRCA1 |
| Interaction | BET1 interactions | 2.39e-04 | 385 | 86 | 8 | int:BET1 | |
| Cytoband | Yq11.223 | 3.38e-05 | 93 | 89 | 4 | Yq11.223 | |
| GeneFamily | RNA binding motif containing | 7.26e-06 | 213 | 61 | 7 | 725 | |
| GeneFamily | ESCRT-0 | 3.35e-05 | 3 | 61 | 2 | 1115 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 7.97e-05 | 25 | 61 | 3 | 775 | |
| GeneFamily | Ribonuclease A family | 8.53e-04 | 13 | 61 | 2 | 723 | |
| GeneFamily | Cadherin related | 1.47e-03 | 17 | 61 | 2 | 24 | |
| GeneFamily | PHD finger proteins | 3.49e-03 | 90 | 61 | 3 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.86e-03 | 34 | 61 | 2 | 487 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.55e-03 | 36 | 61 | 2 | 823 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HIVEP3 TGFBR3 KMT2D RESF1 PTPRJ NFATC2 ATXN1 ARID2 PIEZO1 DOCK9 PPP1R15B TLN1 ITSN2 ZFR TNRC6C HERPUD2 KAT6B VPS13B GATAD2B PCM1 PRDM2 | 1.98e-08 | 1492 | 89 | 21 | M40023 |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 6.02e-08 | 12 | 89 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 6.02e-08 | 12 | 89 | 4 | MM781 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TGFBR3 SEC24D KIF23 HIVEP1 GALK2 BMP2K ATXN1 MICAL2 DOCK9 ITSN2 SEC24B STAM MED13L KAT6B VPS13B | 1.82e-07 | 856 | 89 | 15 | M4500 |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 1.05e-06 | 23 | 89 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 3.64e-06 | 31 | 89 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 4.71e-06 | 33 | 89 | 4 | MM701 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 8.49e-06 | 300 | 89 | 8 | M8702 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.03e-05 | 145 | 89 | 6 | M1810 | |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | 1.87e-05 | 161 | 89 | 6 | M7728 | |
| Coexpression | GSE13887_RESTING_VS_ACT_CD4_TCELL_UP | 3.41e-05 | 108 | 89 | 5 | M478 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN | 5.78e-05 | 197 | 89 | 6 | M8464 | |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | 6.29e-05 | 200 | 89 | 6 | M3510 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | 6.29e-05 | 200 | 89 | 6 | M6514 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 8.22e-05 | 305 | 89 | 7 | M19875 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-07 | 196 | 89 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 182 | 89 | 6 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 182 | 89 | 6 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 182 | 89 | 6 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.97e-06 | 199 | 89 | 6 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.97e-06 | 199 | 89 | 6 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-06 | 199 | 89 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.97e-06 | 199 | 89 | 6 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 89 | 6 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-05 | 152 | 89 | 5 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 163 | 89 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 2.27e-05 | 169 | 89 | 5 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-05 | 174 | 89 | 5 | a75ba49ccea6bd3d78ada1092b46deb5202c58a5 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-05 | 177 | 89 | 5 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.99e-05 | 179 | 89 | 5 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.07e-05 | 180 | 89 | 5 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-05 | 185 | 89 | 5 | fb84fcf7f51f53489bcb3962fa9cb483e48257ed | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.59e-05 | 186 | 89 | 5 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.59e-05 | 186 | 89 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 3.68e-05 | 187 | 89 | 5 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-SCG3+_lymphatic_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.68e-05 | 187 | 89 | 5 | 55aad84b992412e487a32f4970620189a7380ba6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.77e-05 | 188 | 89 | 5 | 34873972dff9284dfcd26bb698c9d1df007f1cbb | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-SCG3+_lymphatic_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.87e-05 | 189 | 89 | 5 | f0418851ad4042c4cd87c8729e4f0d43bdf8fccb | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.97e-05 | 190 | 89 | 5 | d7f1dc032d161529559e01832d1a3112c6f6cc1a | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.07e-05 | 191 | 89 | 5 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.17e-05 | 192 | 89 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-05 | 192 | 89 | 5 | 5388f3115ab285f3f3001af1d71543ed64b9e044 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.27e-05 | 193 | 89 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-05 | 193 | 89 | 5 | ef007b736da56529ec628fc3df86a335e7ec3f18 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.27e-05 | 193 | 89 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.38e-05 | 194 | 89 | 5 | 937ee85ffd50869b60f0f6e91017ab77e8b24c0b | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.60e-05 | 196 | 89 | 5 | ff627244d7f5fd6a2ec009dae32d3509f0e2d95e | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.83e-05 | 198 | 89 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.06e-05 | 200 | 89 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Computational | Neighborhood of IL9 | 1.39e-04 | 93 | 58 | 5 | MORF_IL9 | |
| Computational | Neighborhood of FRK | 3.05e-04 | 110 | 58 | 5 | MORF_FRK | |
| Computational | Neighborhood of DCC | 3.31e-04 | 112 | 58 | 5 | MORF_DCC | |
| Computational | Neighborhood of LCAT | 7.29e-04 | 133 | 58 | 5 | MORF_LCAT | |
| Computational | Neighborhood of EPHA7 | 8.89e-04 | 139 | 58 | 5 | MORF_EPHA7 | |
| Drug | boron trichloride | 3.25e-09 | 6 | 89 | 4 | CID000025135 | |
| Drug | desmethylazelastine | 3.83e-07 | 16 | 89 | 4 | CID000162558 | |
| Drug | molybdenum disulfide | 6.97e-07 | 43 | 89 | 5 | CID000014823 | |
| Drug | propham | 7.85e-07 | 44 | 89 | 5 | CID000024685 | |
| Drug | dazmegrel | 8.08e-07 | 19 | 89 | 4 | CID000053555 | |
| Drug | YM 026 | 8.08e-07 | 19 | 89 | 4 | CID000004443 | |
| Drug | AZFd | 1.82e-06 | 23 | 89 | 4 | CID000196489 | |
| Drug | dansylaziridine | 1.82e-06 | 23 | 89 | 4 | CID000104008 | |
| Drug | d-gluconhydroximo-1,5-lactam | 6.33e-06 | 31 | 89 | 4 | CID000003479 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 7.64e-06 | 183 | 89 | 7 | 7498_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.12e-05 | 194 | 89 | 7 | 3539_DN | |
| Drug | Vistar | 1.17e-05 | 36 | 89 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 1.17e-05 | 36 | 89 | 4 | CID000001649 | |
| Drug | 2-chlorodideoxyadenosine | 2.40e-05 | 43 | 89 | 4 | CID000072194 | |
| Drug | bipy | 3.96e-05 | 97 | 89 | 5 | CID000001474 | |
| Drug | ridogrel | 5.12e-05 | 52 | 89 | 4 | CID005362391 | |
| Drug | azafagomine | 7.36e-05 | 57 | 89 | 4 | CID011957435 | |
| Drug | arabinopyranose | 7.43e-05 | 261 | 89 | 7 | CID000000229 | |
| Disease | Male sterility due to Y-chromosome deletions | 4.89e-09 | 8 | 87 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 4.89e-09 | 8 | 87 | 4 | C1507149 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.35e-05 | 16 | 87 | 3 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.35e-05 | 16 | 87 | 3 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.35e-05 | 16 | 87 | 3 | cv:C1839071 | |
| Disease | monocyte count | HIVEP3 TGFBR3 NMNAT2 HIVEP1 BMP2K ATXN1 PIEZO1 TLN1 ITSN2 CDH23 LTBR MED13L LCT | 1.27e-04 | 1320 | 87 | 13 | EFO_0005091 |
| Disease | hereditary lymphedema (is_implicated_in) | 1.79e-04 | 7 | 87 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | colorectal cancer (is_implicated_in) | 4.61e-04 | 121 | 87 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | endometrial adenocarcinoma (is_marker_for) | 4.65e-04 | 11 | 87 | 2 | DOID:2870 (is_marker_for) | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 6.56e-04 | 13 | 87 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | serum IgE measurement | 9.06e-04 | 64 | 87 | 3 | EFO_0004579 | |
| Disease | cognitive function measurement | NMNAT2 SYNPO2 KMT2D A1CF HIVEP1 ATXN1 PIEZO1 ITSN2 ZFR LMBRD2 MAML3 GATAD2B | 1.01e-03 | 1434 | 87 | 12 | EFO_0008354 |
| Disease | Hemangiosarcoma | 1.28e-03 | 18 | 87 | 2 | C0018923 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.43e-03 | 75 | 87 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 1.74e-03 | 21 | 87 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | myeloid white cell count | 1.77e-03 | 937 | 87 | 9 | EFO_0007988 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.27e-03 | 24 | 87 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | obsessive-compulsive disorder, Tourette syndrome | 2.67e-03 | 26 | 87 | 2 | EFO_0004242, EFO_0004895 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QNVSVPSNNVHAPYS | 146 | Q9GZX9 | |
| YRNSSPQVVPNNSSE | 126 | Q86YH2 | |
| AAAQASAPAQTQAPT | 991 | Q4VCS5 | |
| YAVPNATAPVSAAQL | 546 | Q9NQ94 | |
| SSSPYVSNAVQRDAP | 56 | O15123 | |
| RAPSPQVVYQVASNQ | 1091 | Q68CP9 | |
| PAQQNQYVHISSSPQ | 241 | P54253 | |
| SQQQASPEYLTSPQE | 556 | Q9NSY1 | |
| ITPNPVTQHVQAYSA | 156 | Q13117 | |
| ITPNPVTQHVQAYSA | 156 | Q9NR90 | |
| QAFPAYPNSPVQVTT | 406 | Q9NR90 | |
| PPNNQITYSIVSASA | 591 | Q9H251 | |
| SSQPAAYVAQPATAA | 426 | Q96PK6 | |
| AQNLPDSSPTQNYIS | 481 | Q2KHR3 | |
| EPLSSNQPASVTDYQ | 846 | Q9NZM3 | |
| VNVQPYSGSPANLAV | 136 | P34897 | |
| SQSSYIVHVAENNPP | 451 | Q9UN71 | |
| SPSVPALENSYAQIS | 1616 | Q8WYB5 | |
| YAQISPDQSAISVPS | 1626 | Q8WYB5 | |
| FVPIAPTSTQNYTQE | 191 | Q9BUJ0 | |
| SSPDARYQQQNPAAV | 736 | Q13469 | |
| QASPVIHYSPTNQQL | 806 | Q13469 | |
| DPNSTAQYTRPSNVS | 616 | Q12913 | |
| TSSTIQVAPANYPNE | 2001 | Q71F56 | |
| NPSSSNVIYDEQSPL | 1116 | Q5TCQ9 | |
| APSSQSQAYERNAPQ | 1076 | Q96JK9 | |
| NVPDTNPYRSSAADV | 451 | Q9NRR6 | |
| TQNNPVYQVSFSPQD | 151 | Q96MR6 | |
| NQQALVKTPSYSSAP | 1831 | Q5HYC2 | |
| LPTVDTSAQAAPQTY | 46 | P07992 | |
| PYPTASLVSQNESEN | 466 | Q15154 | |
| YTANPQLVAAEPSAS | 1011 | Q9ULL4 | |
| NDNPPTFSQLVYTTS | 2266 | Q9NYQ8 | |
| PLYPDFSTSANNIQI | 86 | Q01415 | |
| ISNAPQNTCIPSYDT | 691 | P09848 | |
| SQYSPNEIRENSPAV | 521 | Q9Y2L9 | |
| YAAVNITTNQAAPSE | 441 | P54753 | |
| QVPLAAYNLAPESTS | 611 | Q8NG31 | |
| PNVSNYVNSNEIVPV | 301 | A0A087WXM9 | |
| FSIYTQQSQDPPAQK | 426 | O75110 | |
| INYQPQSSSSVPCQR | 296 | Q8WXI9 | |
| SSAITLNIYCQNPPS | 376 | Q7Z2Q7 | |
| PDYQQQAAVPLSSET | 436 | P09923 | |
| PAQSAQSQSSYNPFE | 351 | Q9UNF0 | |
| AADTPAPFSRYQAQN | 151 | Q96ID5 | |
| ITPNPVTQHVQAYSA | 486 | Q9NQZ3 | |
| PYTTSTPNINSVRNA | 1236 | Q9BZ29 | |
| YQNATDVPRTSDPQI | 266 | I3L273 | |
| PSQIQNSTETPSAYD | 511 | Q9Y2E5 | |
| PSIYLNTQQSPVAAT | 261 | P38567 | |
| YQAAVSAQATSNVNP | 206 | Q9BSE4 | |
| ITPNPVTQHVQAYSA | 321 | Q86SG3 | |
| YSALYTVPTQNVTPN | 91 | O95487 | |
| PSIPSYNVSFISQTQ | 476 | Q8TDX9 | |
| QRANSFQSPTPSKYQ | 1231 | O94851 | |
| AQATQNVYVPSTEPE | 531 | Q13029 | |
| VQNDAYTAPALPSSI | 231 | Q9BY77 | |
| SPVPLSSNYIAQISN | 686 | Q02241 | |
| NVYVNSSIPIPSSNS | 166 | P59535 | |
| PSYPAAQSQAKAVAA | 501 | P84550 | |
| VNQDYFASVNAPSNP | 346 | O60763 | |
| QTKEQQSSPNTFAPY | 1251 | Q9HCJ0 | |
| TAIIPASNNPYFRDQ | 836 | Q96KN7 | |
| NSNITGLYATANPVP | 76 | Q68DH5 | |
| AAATPQPQYVTELQS | 46 | P22670 | |
| LPSRQTSAVPSQQYA | 256 | Q9HCM1 | |
| KFANSVPPNVNNAVY | 966 | Q9BZV3 | |
| PYNPQNFTATIQTAA | 486 | Q5SWA1 | |
| SPQNISNCRYAQTPA | 116 | P10153 | |
| NNVASSHAPYQPSAQ | 91 | O94855 | |
| NSIYPPSAAPTAVQQ | 91 | Q9BYN7 | |
| PQAAVASQNYTPKPT | 831 | Q9UMS6 | |
| VNAASPTNVQASSVY | 1011 | Q9UMS6 | |
| SQPDQVTPNCNYLTS | 181 | Q5GAN6 | |
| AQTSQPTNYTVAPAS | 331 | Q92734 | |
| AQAAYLVGVSDPNSQ | 1441 | Q9Y490 | |
| EEAPYQQSTSPQRVS | 61 | Q9Y2P7 | |
| QYPVSAQAPNSAITA | 516 | Q9H0E3 | |
| YQNVASQAPQSLPAI | 671 | O14964 | |
| EQQVSPPNTNAKSYA | 401 | Q5T1R4 | |
| SANPALPSQQTQAAY | 446 | Q92783 | |
| AASQPQAVPPYASEN | 26 | P36941 | |
| SASDQPYQRETPQVS | 611 | O43296 | |
| NLQVATYSKFQPQSP | 116 | Q92890 | |
| VAAAAQPQPSVAETY | 171 | Q96KR1 | |
| TAAPQYLQPFVSDRN | 2501 | Q7Z7G8 | |
| CANEPSQAVSVTNPY | 466 | P35968 | |
| PRPSAQSAFQLAYQA | 1436 | Q92508 | |
| SAQQPSIIPFTAQAY | 2226 | Q92508 | |
| SSPFYQSHQSPVAQQ | 286 | O15016 | |
| FQNTALPSVNAVPYQ | 1451 | P15822 | |
| ELITPNSNPYSAFQV | 236 | Q03167 | |
| QTTPDYSPQEAFTNA | 76 | P52435 | |
| STISPVLYANINFPN | 2016 | O14686 | |
| PIYQNSNVATKPTAA | 136 | Q9BZQ4 |